Literature DB >> 23771961

Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis.

Lennart Tonneijck1, Anisha Tanna, Charles D Pusey.   

Abstract

A 72-year-old male patient with known diffuse cutaneous systemic sclerosis (SSc) presented with severe haemoptysis and blood and protein in the urine. In light of his known interstitial lung disease, he had been repeatedly treated for recurrent community-acquired pneumonia. Immunological testing demonstrated a strongly positive perinuclear antineutrophil cytoplasm antibody with a high titre antimyeloperoxidase antibody. The patient was diagnosed with pulmonary-renal syndrome as a consequence of antineutrophil cytoplasm antibody-associated vasculitis. He started immediate plasmapheresis in combination with methylprednisolone, followed by cyclophosphamide and rituximab, with good clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23771961      PMCID: PMC3703084          DOI: 10.1136/bcr-2012-008099

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Anti-neutrophil antibody associated vasculitis in systemic sclerosis.

Authors:  Uri Arad; Alexandra Balbir-Gurman; Keren Doenyas-Barak; Mirit Amit-Vazina; Dan Caspi; Ori Elkayam
Journal:  Semin Arthritis Rheum       Date:  2011-02-01       Impact factor: 5.532

Review 2.  Epidemiology of systemic sclerosis.

Authors:  Mandana Nikpour; Wendy M Stevens; Ariane L Herrick; Susanna M Proudman
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

3.  Management of alveolar hemorrhage in lung vasculitides.

Authors:  Alina Casian; David Jayne
Journal:  Semin Respir Crit Care Med       Date:  2011-06-14       Impact factor: 3.119

4.  Epidemiology of ANCA-associated vasculitis.

Authors:  Eleana Ntatsaki; Richard A Watts; David G I Scott
Journal:  Rheum Dis Clin North Am       Date:  2010-06-15       Impact factor: 2.670

5.  Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis.

Authors:  Nicholas Mansfield; Sally Hamour; Anne-Marie Habib; Ruth Tarzi; Jeremy Levy; Megan Griffith; Tom Cairns; H Terence Cook; Charles D Pusey; Alan D Salama
Journal:  Nephrol Dial Transplant       Date:  2011-03-17       Impact factor: 5.992

Review 6.  Corticosteroids and the risk of scleroderma renal crisis: a systematic review.

Authors:  Gerald Trang; Russell Steele; Murray Baron; Marie Hudson
Journal:  Rheumatol Int       Date:  2010-12-04       Impact factor: 2.631

7.  Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.

Authors:  Nishkantha Arulkumaran; Naomi Periselneris; Gill Gaskin; Nicola Strickland; Philip W Ind; Charles D Pusey; Alan D Salama
Journal:  Rheumatology (Oxford)       Date:  2011-08-25       Impact factor: 7.580

8.  Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care.

Authors:  Christian Rabe; Beate Appenrodt; Christian Hoff; Santiago Ewig; Hans Ulrich Klehr; Tilman Sauerbruch; Georg Nickenig; Selçuk Tasci
Journal:  J Crit Care       Date:  2009-07-09       Impact factor: 3.425

Review 9.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.